Smith & Nephew plc (NYSE:SNN) – Investment analysts at Jefferies Financial Group issued their FY2023 EPS estimates for shares of Smith & Nephew in a research report issued to clients and investors on Tuesday, January 21st. Jefferies Financial Group analyst K. Lee anticipates that the medical equipment provider will post earnings of $2.82 per share for the year. Jefferies Financial Group also issued estimates for Smith & Nephew’s FY2024 earnings at $3.00 EPS.
Other equities analysts also recently issued reports about the stock. Zacks Investment Research raised shares of Smith & Nephew from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a research note on Wednesday, January 15th. ValuEngine downgraded shares of Smith & Nephew from a “hold” rating to a “sell” rating in a research note on Friday, January 3rd. Sanford C. Bernstein began coverage on shares of Smith & Nephew in a research note on Tuesday, November 12th. They issued an “outperform” rating for the company. Finally, Citigroup began coverage on shares of Smith & Nephew in a research note on Thursday, November 21st. They issued a “buy” rating for the company. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. Smith & Nephew has an average rating of “Buy” and a consensus price target of $30.00.
SNN stock opened at $50.57 on Thursday. Smith & Nephew has a 1 year low of $37.30 and a 1 year high of $50.69. The company has a market cap of $21.79 billion, a P/E ratio of 25.03, a PEG ratio of 4.20 and a beta of 0.26. The firm has a 50-day moving average of $47.74 and a 200 day moving average of $46.05. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.00 and a quick ratio of 0.96.
Hedge funds have recently added to or reduced their stakes in the stock. Evoke Wealth LLC bought a new position in Smith & Nephew in the third quarter worth about $25,000. Whittier Trust Co. bought a new position in Smith & Nephew in the third quarter worth about $26,000. AdvisorNet Financial Inc grew its holdings in Smith & Nephew by 82.4% in the third quarter. AdvisorNet Financial Inc now owns 664 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 300 shares during the period. Huntington National Bank grew its holdings in Smith & Nephew by 362.9% in the fourth quarter. Huntington National Bank now owns 787 shares of the medical equipment provider’s stock worth $38,000 after purchasing an additional 617 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Smith & Nephew in the fourth quarter worth about $38,000. 8.90% of the stock is owned by institutional investors.
About Smith & Nephew
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.
Recommended Story: What is Liquidity?
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.